Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.
Daniel H SolomonDemler V OlgaPamela M RistLeah M SantacroceAhmed TawakolJon T GilesKatherine P LiaoJoan M BathonPublished in: Journal of the American Heart Association (2024)
A candidate biomarker approach identified several promising biomarkers that associate with baseline and treatment-associated changes in arterial inflammation in patients with RA. These will now be tested in an external validation cohort.